Microbiology and management of polymicrobial female genital tract infections in adolescents

Journal of Pediatric and Adolescent Gynecology

Volumn 15, Issue 4, 2002, Pages 217-226

  Brook, Itzhak ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Adolescent; Anaerobic bacteria; Female genital tract infections; Neisseria gonorrhoeae; Pelvic inflammatory disease

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; MACROLIDE; METRONIDAZOLE; OFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; SPIRAMYCIN; SULTAMICILLIN; TICARCILLIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BARTHOLIN GLAND; CONDYLOMA ACUMINATUM; CONFERENCE PAPER; DRUG CHOICE; ENDOMETRITIS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GARDNERELLA VAGINALIS; GENITAL TRACT INFECTION; HERPES SIMPLEX; HUMAN; MICROBIOLOGICAL EXAMINATION; NEISSERIA GONORRHOEAE; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PELVIS ABSCESS; PRIORITY JOURNAL; SALPINGITIS; SEXUALLY TRANSMITTED DISEASE; STREPTOCOCCACEAE; TUBOOVARIAN ABSCESS; VULVOVAGINITIS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ENDOMETRITIS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; PELVIC INFLAMMATORY DISEASE; SALPINGITIS; VULVOVAGINITIS;

EID: 0036435138     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-3188(02)00159-6     Document Type: Conference Paper

References (58)

1. Smith MS, Eschenbach DA: Pelvic inflammatory disease: A review. Clin Pediatr 1980; 19:791
2. Forslin L, Falk V, Danielson D: Changes in the incidence of acute gonococcal and non-gonococcal salpingitis. Br J Vener Dis 1978; 54:247
3. Gorbach SL, Menda KB, Thadepalli H, Keith L: Anaerobic microflora of the cervix in healthy women. Am J Obstet Gynecol 1973; 117:1053
4. Larsen B, Galask RP: Vaginal microbial flora and theoretic relevance. Obstet Gynecol 1980; 55(suppl):100
5. Hammerschlag MR, Alpert S, Onderdonk AB, et al: Anaerobic microflora of the vagina in children. Am J Obstet Gynecol 1978; 131:853
6. Singleton AF: Vaginal discharge in children and adolescents. Evolution and management: A review. Clin Pediatr 1980; 19:799
7. Sobel JD: Individualizing treatment of vaginal canal. Am Acad Dermatol 1990; 23:572
8. Murphy TV, Nelson JD: Shigella vaginitis: Report of 38 patients and review of the literature. Pediatrics 1979; 63:511
9. Watkins S, Quan L: Vulvovaginitis caused by Yersinia enterocolitica. Pediatr Infect Dis J 1984; 3:444
10. Sweet RL: Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995; 20(Suppl 2):S271
11. Emans JS: Vulvovaginitis in the child and adolescent. Pediatr Rev 1986; 8:12
12. Spiegel CA, Eschenbach DA, Amsel R, Holmes KK: Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy. J Infect Dis 1983; 148:817
13. Hammerschlag MR, Cummings M, Doraiswamy B, Cox P, McCormack WM: Nonspecific vaginitis following sexual abuse in children. Pediatrics 1985; 75:1028
14. Schmitt C, Sobel JD, Meriwether C: Bacterial vaginosis: Treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 1992; 79:1020
15. Bristoletti P, Fredricsson B, Hagstrom B, et al: Comparison of oral and vaginal metronidazole therapy for nonspecific bacterial vaginosis. Gynecol Obstet Invest 1986; 21:144
16. Swedberg J, Steiner JF, Deiss F, et al: Comparison of single dose vs one week of metronidazole for symptomatic bacterial vaginosis. JAMA 1985; 254:1046
17. Hill GB, Livengood CH III: Bacterial vaginosis-associated microflora and effects of topical intravaginal clindamycin. Am J Obstet Gynecol 1994; 171:1198
18. Parker RT, Jones CP: Anaerobic pelvic infections and developments in hyperbaric oxygen therapy. Am J Obstet Gynecol 1966; 96:645
19. Swenson RM, Michaelson TC, Daly MJ, Spaulding EH: Anaerobic bacterial infections of the female genital tract. Obstet Gynecol 1973; 42:538
20. van Bogaert LJ: Management of Bartholin's abscess. World Health Forum 1997; 18:200
21. Brook I: Anaerobic bacteria in suppurative genitourinary infections. J Urol 1989; 141:889
22. Brook I: Aerobic and anaerobic microbiology of Bartholin's abscess. Surg Gynecol Obstet 1989; 169:32
23. Roberts DB, Hester LL Jr: Progressive synergistic bacterial gangrene arising from abscesses of the vulva and Bartholin's gland duct. Am J Obstet Gynecol 1972; 114:285
24. Hill DA, Lense JJ: Office management of Bartholin gland cysts and abscesses. Am Fam Physician 1998; 1(57): 1611, 1619
25. Ross J: Pelvic inflammatory disease. BMJ 2001; 322:658
26. Hillier SL, Kiviat NB, Hawes SE, et al: Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996; 175:435
27. Carter B: A bacteriologic and clinical study of pyometra. Am J Obstet Gynecol 1951; 62:793
28. Muram D, Drouin P, Thompson FE, Oxorn H: Pyometra. Can Med Assoc J 1981; 125:589
29. Henriksen E: Pyometra associated with malignant lesions of the cervix and the uterus. Am J Obstet Gynecol 1956; 72:884
30. Eschenbach DA, Buchanan TM, Pollock HM, et al: Polymicrobial etiology of pelvic inflammatory disease. N Engl J Med 1975; 293:166
31. Cunningham FG, Hauth JC, Strong JD, et al: Evaluation of tetracycline or penicillin and ampicillin for treatment of acute pelvic inflammatory disease. N Engl J Med 1977; 296:1380
32. Soper DE, Brockwell NJ, Dalton HP, Johnson D: Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994; 170:1008
33. Walker CK, Workowski KA, Washington AE, Soper D, Sweet RL: Anaerobes in pelvic inflammatory disease: Implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases. Clin Infect Dis 1999; 28(Suppl 1):S29
34. Brook I: The role of β-lactamase-producing bacteria in obstetrical and gynecological infections. Gynecol Obstet Invest 1991; 32:44
35. Brook I: Induction of subcutaneous and intraperitoneal abscesses in mice by Neisseria gonorrhoeae and Bacteroides sp. Am J Obstet Gynecol 1986; 155:424
36. Draper DL, James JF, Brooks GF, Sweet RL: Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis. Infect Immun 1980; 27:882
37. Trenharne JD, Ripa KT, Mardh PA, Svensson L, Westrom L, Darougar S: Antibodies to Chlamydia trachomatis in acute salpingitis. Br J Vener Dis 1979; 55:26
38. Paavonen J, Saikku P, Vesterinen E, Aho K: Chlamydia trachomatis in acute salpingitis. Br J Vener Dis 1979; 55:203
39. Dieterle S, Rummel C, Bader LW, Petersen H, Fenner T: Presence of the major outer-membrane protein of Chlamydia trachomatis in patients with chronic salpingitis and salpingitis isthmica nodosa with tubal occlusion. Fertil Steril 1998; 70:774
40. Mardh PA, Westrom L: Tubal and cervical cultures in acute salpingitis with special reference to Mycoplasma hominis and T-strain mycoplasma. Br J Vener Dis 1970; 46:179
41. Heinonen PK, Miettinen A: Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol 1994; 57:85
42. Centers for Disease Control: Pelvic inflammatory disease: Guidelines for prevention and management. MMWR 1991; 40(RR-5):1
43. Sweet RL: Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995; Suppl 2:S271
44. Brook I: Anaerobic infection in children. Adv Pediatr 2000; 47:395
45. Brook I: Metronidazole and spiramycin effect on Bacteroides sp. Staphylococcus aureus abscess. J Antimicrobial Chemother 1987; 20:713
46. Centers for Disease Control and Prevention: 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1998; 47(RR-1):79
47. Wasserheit JN, Bell TA, Kiviat NB, et al: Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986; 104:187
48. Beerthuizen RJ: Pelvic inflammatory disease in intrauterine device users. Eur J Contracept Reprod Health Care 1996; 1:237
49. Atad J, Hallak M, Sharon A, Kitzes R, Kelner Y, Abramovici H: Pelvic actinomycosis. Is long-term antibiotic therapy necessary? Reprod Med 1999; 44:939
50. Taylor ES, McMillan JH, Greer BE, Droegemueller W, Thompson HE: The intrauterine device and tubo-ovarian abscess. Am J Obstet Gynecol 1975; 123:338
51. Kirby BD, George WL, Sutter VL, Citron DM, Finegold SM: Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little known Bacteroides sp. Rev Infect Dis 1980; 2:914
52. Thadepalli H, Gorbach SL, Keith L: Anaerobic infections of the female genital tract: Bacteriologic and therapeutic aspects. Am J Obstet Gynecol 1973; 117:1034
53. Landers DV, Sweet RL: Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol 1985; 151:1098
54. Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen J: MR imaging in pelvic inflammatory disease: Comparison with laparoscopy and US. Radiology 1999; 210:209
55. Apter S, Shmamann S, Ben-Baruch G, Rubinstein ZJ, Barkai G, Hertz M: CT of pelvic infection after cesarean section. Clin Exp Obstet Gynecol 1992; 19:156
56. Slap GB, Forke CM, Cnaan A, et al: Recognition of tubo-ovarian abscess in adolescents with pelvic inflammatory disease. J Adolesc Health 1996; 18:397
57. Perez-Medina T, Huertas MA, Bajo JM: Early ultrasound-guided transvaginal drainage of tubo-ovarian abscesses: A randomized study. Ultrasound Obstet Gynecol 1996; 7:435
58. Caspi B, Zalel Y, Or Y, Bar Dayan Y, Appelman Z, Katz Z: Sonographically guided aspiration: An alternative therapy for tubo-ovarian abscess. Ultrasound Obstet Gynecol 1996; 7:439